← Evidence map

ArticleBiology2026

Lisosan G as a Modulator of Serum Lipid/Lipoprotein Changes, Lipid Metabolism and TGF-β1 Level in Neoplastic and Non-Neoplastic Liver Injury: A Rat Model Study.

Bartłomiej Szymczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Lisosan G as a Modulator of Serum Lipid/Lipoprotein Changes, Lipid Metabolism and TGF-β1 Level in Neoplastic and Non-Neoplastic Liver Injury: A Rat Model Study. | Socratic